SEC Form 4 · accession 0001596783-17-000057
Catalent, Inc. · CTLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wetteny Joseph
Officer — President - CSS
Period of report
Jul 24, 2017
Accepted (ET)
Jul 26, 2017 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596783
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 24, 2017 | A | 2,221 | $0.00 | A | 11,270 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF3,F4 | $36.02 | Jul 24, 2017 | A | 11,528 | A | — | Jul 24, 2027 | Common Stock | 11,528 | 11,528 | D |
Explanation of responses
- F1Restricted stock units received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
- F2Includes restricted stock units.
- F3Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
- F4The options vest in four equal annual installments beginning on July 24, 2018.
Remarks
President - Clinical Supply Services